Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Gains from Sales and Divestitures (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $7195.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures fell 5.59% to $7195.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7195.0 through Dec 2025, down 5.59% year-over-year, with the annual reading at $7195.0 for FY2025, 5.59% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $7195.0 at bioAffinity Technologies, up from $5628.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $172660.0 in Q2 2025, with the low at $106.0 in Q3 2024.
  • Average Gains from Sales and Divestitures over 4 years is $39217.2, with a median of $9178.5 recorded in 2024.
  • The sharpest move saw Gains from Sales and Divestitures plummeted 87.09% in 2024, then surged 5209.43% in 2025.
  • Over 4 years, Gains from Sales and Divestitures stood at $29728.0 in 2022, then surged by 98.64% to $59051.0 in 2023, then tumbled by 87.09% to $7621.0 in 2024, then fell by 5.59% to $7195.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $7195.0, $5628.0, and $172660.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.